NO892172L - Fremgangsmaate for fremstilling av et modifisert baculovirus. - Google Patents
Fremgangsmaate for fremstilling av et modifisert baculovirus.Info
- Publication number
- NO892172L NO892172L NO89892172A NO892172A NO892172L NO 892172 L NO892172 L NO 892172L NO 89892172 A NO89892172 A NO 89892172A NO 892172 A NO892172 A NO 892172A NO 892172 L NO892172 L NO 892172L
- Authority
- NO
- Norway
- Prior art keywords
- baculovirus
- modified
- procedure
- preparation
- modified baculovirus
- Prior art date
Links
- 241000701447 unidentified baculovirus Species 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8807207A FR2631974B1 (fr) | 1988-05-31 | 1988-05-31 | Baculovirus modifie, son procede de preparation et son application en tant que vecteur d'expression de genes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO892172D0 NO892172D0 (no) | 1989-05-30 |
| NO892172L true NO892172L (no) | 1989-12-01 |
Family
ID=9366759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89892172A NO892172L (no) | 1988-05-31 | 1989-05-30 | Fremgangsmaate for fremstilling av et modifisert baculovirus. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5583023A (no) |
| EP (1) | EP0345152B1 (no) |
| JP (1) | JP3183877B2 (no) |
| AT (1) | ATE142257T1 (no) |
| AU (1) | AU626867B2 (no) |
| CA (1) | CA1341272C (no) |
| DE (1) | DE68927073T2 (no) |
| DK (1) | DK263689A (no) |
| FR (1) | FR2631974B1 (no) |
| NO (1) | NO892172L (no) |
| NZ (1) | NZ229369A (no) |
| PT (1) | PT90687B (no) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244805A (en) * | 1989-05-17 | 1993-09-14 | University Of Georgia Research Foundation, Inc. | Baculovirus expression vectors |
| JPH04501065A (ja) * | 1989-05-17 | 1992-02-27 | ユニバーシティ オブ ジョージア リサーチ ファウンデーション インコーポレイテッド | 改良されたバキュロウイルス発現ベクター |
| GB9106185D0 (en) * | 1991-03-22 | 1991-05-08 | Wellcome Found | Biological control agents |
| TW502065B (en) * | 1993-05-28 | 2002-09-11 | American Cyanamid Co | Gene insertion by direct ligation in vitro |
| FR2724182B1 (fr) * | 1994-09-02 | 1996-12-13 | Pasteur Institut | Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations |
| FR2724393A1 (fr) * | 1994-09-12 | 1996-03-15 | Inst Nat Sante Rech Med | Obtention d'un anticorps monoclonal recombinant humanise a partir d'un anticorps monoclonal murin, sa production en cellules d'insecte, et ses utilisations |
| FR2732035B1 (fr) * | 1995-03-23 | 1997-05-30 | Agronomique Inst Nat Rech | Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede |
| DE69841023D1 (de) | 1997-03-12 | 2009-09-10 | Applied Biosystems Llc | DNA Polymerasen mit verbesserten Fähigkeiten zum Einbau von markierten Nukleotiden |
| US20050042629A1 (en) | 2002-09-13 | 2005-02-24 | Applera Corporation | Thermus scotoductus nucleic acid polymerases |
| ES2411007T3 (es) | 2001-10-10 | 2013-07-04 | Novo Nordisk A/S | Remodelación y glicoconjugación de péptidos |
| US7052877B2 (en) | 2001-11-30 | 2006-05-30 | Applera Corporation | Thermus brockianus nucleic acid polymerases |
| PL1615945T3 (pl) | 2003-04-09 | 2012-03-30 | Ratiopharm Gmbh | Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami |
| BRPI0507169A (pt) | 2004-02-02 | 2007-06-26 | Ambrx Inc | polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos |
| US7632924B2 (en) | 2004-06-18 | 2009-12-15 | Ambrx, Inc. | Antigen-binding polypeptides and their uses |
| WO2006091231A2 (en) | 2004-07-21 | 2006-08-31 | Ambrx, Inc. | Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| CN103520735B (zh) * | 2004-12-22 | 2015-11-25 | Ambrx公司 | 包含非天然编码的氨基酸的人生长激素配方 |
| EP2399893B1 (en) | 2004-12-22 | 2018-08-15 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| BRPI0519430A2 (pt) | 2004-12-22 | 2009-02-10 | Ambrx Inc | hormânio do crescimento humano modificado |
| EP1836298B1 (en) * | 2004-12-22 | 2012-01-18 | Ambrx, Inc. | COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
| EP1836316A4 (en) | 2004-12-22 | 2009-07-22 | Ambrx Inc | PROCESS FOR EXPRESSION AND CLEANING OF RECOMBINANT HUMAN GROWTH HORMONE |
| AU2006255122B2 (en) * | 2005-06-03 | 2010-10-21 | Ambrx, Inc. | Improved human interferon molecules and their uses |
| AU2005335491B2 (en) | 2005-08-18 | 2010-11-25 | Ambrx, Inc. | Compositions of tRNA and uses thereof |
| CN101400646A (zh) * | 2005-11-08 | 2009-04-01 | Ambrx公司 | 用于修饰非天然氨基酸和非天然氨基酸多肽的促进剂 |
| DK2339014T3 (en) * | 2005-11-16 | 2015-07-20 | Ambrx Inc | Methods and compositions comprising non-natural amino acids |
| US7745158B2 (en) * | 2005-12-14 | 2010-06-29 | Kimberly-Clark Worldwide, Inc. | Detection of secreted aspartyl proteases from Candida species |
| WO2007070659A2 (en) * | 2005-12-14 | 2007-06-21 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| JP5399906B2 (ja) * | 2006-09-08 | 2014-01-29 | アンブルックス,インコーポレイテッド | 脊椎動物細胞用のハイブリッドサプレッサーtrna |
| EP2064333B1 (en) * | 2006-09-08 | 2014-02-26 | Ambrx, Inc. | Suppressor trna transcription in vertebrate cells |
| CN106008699A (zh) * | 2006-09-08 | 2016-10-12 | Ambrx公司 | 经修饰的人类血浆多肽或Fc骨架和其用途 |
| CN107501407B (zh) | 2007-03-30 | 2022-03-18 | Ambrx公司 | 经修饰fgf-21多肽和其用途 |
| US8114630B2 (en) * | 2007-05-02 | 2012-02-14 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
| MX2010005317A (es) | 2007-11-20 | 2010-06-02 | Ambrx Inc | Polipeptidos de insulina modificados y sus usos. |
| MX344166B (es) | 2008-02-08 | 2016-12-07 | Ambrx Inc | Leptina-polipeptidos modificados y sus usos. |
| CN102159230A (zh) | 2008-07-23 | 2011-08-17 | Ambrx公司 | 经修饰的牛g-csf多肽和其用途 |
| AU2009296267B2 (en) * | 2008-09-26 | 2013-10-31 | Ambrx, Inc. | Non-natural amino acid replication-dependent microorganisms and vaccines |
| BR122012024318A2 (pt) | 2008-09-26 | 2019-07-30 | Ambrx, Inc. | Polipeptídeos modificados de eritropoetina animal e seus usos |
| BR112012015597A2 (pt) | 2009-12-21 | 2017-01-31 | Ambrx Inc | peptídeos de somatotropina suínos modificados e seus usos |
| MX349301B (es) | 2009-12-21 | 2017-07-21 | Ambrx Inc | Polipéptidos de somatotropina bovina modificados y sus usos. |
| US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
| EA030886B1 (ru) | 2010-08-17 | 2018-10-31 | Амбркс, Инк. | Модифицированные полипептиды релаксина, содержащие некодируемую в природе аминокислоту, связанную с полимером, и их применение |
| TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
| US20140017263A1 (en) | 2012-06-28 | 2014-01-16 | Clemson University | Delivery Agents for Targeted Treatment of Elastin Degradation |
| CN105264076B (zh) | 2013-01-28 | 2019-09-13 | 堪萨斯州立大学研究基金会 | 裂谷热病毒糖蛋白gn和gc及其用途 |
| CN114805532A (zh) | 2014-10-24 | 2022-07-29 | 百时美施贵宝公司 | 修饰的fgf-21多肽及其用途 |
| PE20191716A1 (es) | 2017-02-08 | 2019-12-05 | Bristol Myers Squibb Co | Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos |
| TWI744705B (zh) * | 2018-10-18 | 2021-11-01 | 中央研究院 | 偵測殺蟲劑的方法及套組、以及製備偵測殺蟲劑之方法及套組的質體、桿狀病毒、細胞及方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1202581A (en) * | 1980-03-27 | 1986-04-01 | Saran A. Narang | Adaptor molecules for dna and their application to synthesis of gene-derived products |
| US4419446A (en) * | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
| EP0074808A3 (en) * | 1981-09-16 | 1984-07-04 | University Patents, Inc. | Recombinant method and materials |
| EP0127839B1 (en) * | 1983-05-27 | 1992-07-15 | THE TEXAS A&M UNIVERSITY SYSTEM | Method for producing a recombinant baculovirus expression vector |
| FR2571737B1 (fr) * | 1984-10-15 | 1987-02-20 | Agronomique Inst Nat Rech | Vecteurs de clonage ou d'expression comportant le genome du virus de l'erythroblastose aviaire et cellules transfectees par ces vecteurs |
| JPS63167797A (ja) * | 1985-12-18 | 1988-07-11 | マイクロジエネシス,インコ−ポレイテイド | 選択された昆虫宿主細胞中で選択されたポリペプチドを製造する方法 |
| JPH02502876A (ja) * | 1987-03-16 | 1990-09-13 | アメリカン バイオジェネティック サイエンシズ インク | ワクチンと生物学的殺虫剤における組換えバクロウイルス閉塞体 |
| JPH02504103A (ja) * | 1987-06-30 | 1990-11-29 | ジ・アップジョン・カンパニー | 減少したo‐連結グリコシレーションを有するウイルスタンパク質 |
| AU2136788A (en) * | 1987-07-24 | 1989-03-01 | Cetus Corporation | Production of ricin toxins in a baculovirus-insect cell expression system |
-
1988
- 1988-05-31 FR FR8807207A patent/FR2631974B1/fr not_active Expired - Lifetime
-
1989
- 1989-05-29 CA CA000600958A patent/CA1341272C/fr not_active Expired - Fee Related
- 1989-05-29 AU AU35291/89A patent/AU626867B2/en not_active Ceased
- 1989-05-30 NO NO89892172A patent/NO892172L/no unknown
- 1989-05-30 PT PT90687A patent/PT90687B/pt not_active IP Right Cessation
- 1989-05-30 DK DK263689A patent/DK263689A/da not_active Application Discontinuation
- 1989-05-31 EP EP89401483A patent/EP0345152B1/fr not_active Expired - Lifetime
- 1989-05-31 AT AT89401483T patent/ATE142257T1/de not_active IP Right Cessation
- 1989-05-31 NZ NZ229369A patent/NZ229369A/xx unknown
- 1989-05-31 DE DE68927073T patent/DE68927073T2/de not_active Expired - Fee Related
- 1989-05-31 JP JP13898789A patent/JP3183877B2/ja not_active Expired - Fee Related
-
1994
- 1994-12-14 US US08/355,824 patent/US5583023A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0235092A (ja) | 1990-02-05 |
| EP0345152B1 (fr) | 1996-09-04 |
| JP3183877B2 (ja) | 2001-07-09 |
| PT90687A (pt) | 1989-11-30 |
| CA1341272C (fr) | 2001-07-10 |
| EP0345152A1 (fr) | 1989-12-06 |
| PT90687B (pt) | 1994-10-31 |
| AU626867B2 (en) | 1992-08-13 |
| DK263689A (da) | 1989-12-01 |
| ATE142257T1 (de) | 1996-09-15 |
| US5583023A (en) | 1996-12-10 |
| NO892172D0 (no) | 1989-05-30 |
| DE68927073T2 (de) | 1997-03-27 |
| NZ229369A (en) | 1991-07-26 |
| DK263689D0 (da) | 1989-05-30 |
| FR2631974B1 (fr) | 1992-12-11 |
| FR2631974A1 (fr) | 1989-12-01 |
| DE68927073D1 (de) | 1996-10-10 |
| AU3529189A (en) | 1989-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO892172D0 (no) | Fremgangsmaate for fremstilling av et modifisert baculovirus. | |
| LU91304I2 (fr) | A tryn-antithrombin alfa | |
| ATE283916T1 (de) | Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen | |
| ES532825A0 (es) | Un metodo de sintetizar un polipeptido seleccionado | |
| BR9609521A (pt) | Fator de crescimento de tecido conectivo | |
| DK645887D0 (da) | Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse | |
| ATE486942T1 (de) | Klonierung und verwendung einer neuen nukleotidsequenz welche bakterielle glukose-6- phosphat isomerase (gpi) kodiert | |
| YU193887A (en) | PROCESS FOR OBTAINING APOLYPOPROTEINE "Al" | |
| DE69217144D1 (de) | Regulator-DNA zur Gen-Expression | |
| GR860914B (en) | Expression of immunologically reactive viral proteins | |
| PT83968B (pt) | Processo para melhoramento da expressao de proteina eucariotica, de preparacao de um plasmideo e plasmideo | |
| FI953525A0 (fi) | Kemiskt syntetiseringsfoerfarande foer framstaellning av ett protein eller en polypeptid | |
| DE3751893D1 (de) | Polypeptid und dessen Herstellung | |
| FI934023A0 (fi) | Human follikelstimulerande hormon receptor | |
| AU5315790A (en) | Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by p. falciparum at the sporozoite stage and in the hepatocytes | |
| AU7542187A (en) | Light inducible promoter | |
| NO874704L (no) | Minaktivin fremstilt ved rekombinant dna-teknikk. | |
| EP0257721A3 (en) | Vaccine | |
| ATE116687T1 (de) | Stamm ral-4, nützlich zur herstellung kleiner proteine und peptide. | |
| DE3780629D1 (no) | ||
| SE9101740D0 (sv) | Nya dna fragment och sekvenser | |
| JPS6474988A (en) | Synthetic gene of cystatin c, corresponding recombinant plasmid and recombinant |